Elevator Pitch
Decoy Therapeutics is engineering broad-acting antivirals that target the viruses of today and preemptively protect against the viruses of tomorrow.
Description
The 21st century is experiencing epidemics and pandemics with increasing frequency, and the world needs new tools to combat these diseases. Decoy's platform engineers new pan-viral drugs that address both existing and new zoonotic viral threats. Our lead antiviral nasal spray has demonstrated activity across the sarbecovirus group of coronaviruses as well as all the variants of SARS-CoV-2; expected clinical entry 2023.
Technology Description
We build peptide conjugates with a targeting moiety, a proprietary linker system and antiviral warheads that inhibit conserved viral functions required for viral fitness.